Upcoming Login Downtime
We're updating the Biocentury.com platform login experience to make access more secure and reliable. As part of this update, logins will be temporarily unavailable on Sunday, March 16, from 4:00AM to 4:00PM GMT. We recognize the inconvenience and appreciate your understanding. Please check back after the maintenance period.
For updates, questions, or issues, please call us at +1 650-552-4224 or email us at support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Cancure LLC (Canzx Biotherapeutics)
Headquarters: Seattle, WA, United States of America
Website: https://www.cancurellc.com/
Year Founded: 2013
Status: Private
BioCentury | Jun 11, 2020
Deals
Cullinan adds first-in-class asset in hot NK cell checkpoint space
Via a deal with Avalon, Cullinan forms new single-asset unit with $26M series A to house anti-MICA mAb
BioCentury | Jun 8, 2018
Tools & Techniques
NK cell check-in
How new NK cell targets could lead to more powerful checkpoint inhibitors
BioCentury | Jun 29, 2017
Product R&D
Drop the MIC
CanCure, Novelogics join Innate in a race for mAbs against soluble MICs
Items per page:
1 - 4 of 4